Scientists test shot to block deadly mosquito viruses
NCT ID NCT06899802
Summary
This study is testing a new vaccine designed to protect adults at high risk from serious brain infections caused by specific mosquito-borne viruses. Researchers are giving the vaccine to 411 healthy volunteers to find the best dose and schedule, and to check how safe it is and if it triggers a strong immune response. The goal is to prevent diseases like Venezuelan and Eastern equine encephalitis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research
Sacramento, California, 95864, United States
-
Benchmark Research
Kenner, Louisiana, 70065, United States
-
Benchmark Research
San Angelo, Texas, 76904, United States
-
Clay-Platte Family Medicine, P.C./CCT Research
Kansas City, Missouri, 64151, United States
-
Jefferson City Medical Group / Avacare
Jefferson City, Missouri, 65109, United States
-
Johnson County Clin-Trials
Lenexa, Kansas, 66219, United States
-
Lifeline Primary Care, Inc. / CCT Research
Lilburn, Georgia, 30047, United States
-
Papillion Research Center/CCT Research
Papillion, Nebraska, 68046, United States
-
Versailles Family Medicine, PLLC/CCT Research
Versailles, Kentucky, 40383, United States
Conditions
Explore the condition pages connected to this study.